Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician. (Q38077713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

review article

1 reference

title

Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

main subject

cardiovascular disease

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Rejane F Dillenburg

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Paul Nathan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

30 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pediatrics

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

1149-1160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Temporal trends in cause-specific late mortality among 5-year survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

The perfect storm: Torsades de Pointes in a child with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

The role of corrected QT interval in the cardiologic follow-up of young patients treated with Adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Survival of European children and young adults with cancer diagnosed 1995–2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

The cardiotoxicity of adriamycin and daunomycin in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiac involvement in bone marrow transplantation: serial changes in left ventricular size, mass and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Mortality experiences among 15+ year survivors of childhood and adolescent cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Anthracycline associated cardiotoxicity in survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Tomorrow's targeted therapies in breast cancer patients: what is the risk for increased radiation-induced cardiac toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Long-term survivors of childhood cancers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

A mouse model of radiation-induced cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiac side-effects of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiac toxicity of high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Chronic health conditions in adult survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Associated cardiac lesions in patients with radiation-induced complete heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Isovolumic acceleration at rest and during exercise in children normal values for the left ventricle and first noninvasive demonstration of exercise-induced force-frequency relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

The use of liposomal anthracycline analogues for childhood malignancies: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiotoxicity of cancer chemotherapy: implications for children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Radiation injury to the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Prevalence, characteristics and natural course of inappropriate sinus tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiac damage after treatment of childhood cancer: a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Long-term cardiac follow-up of children treated with anthracycline doses of 300â mg/m2or less for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-013-1931-9

Medical assessment of adverse health outcomes in long-term survivors of childhood cancer

21 January 2018

1 reference

12 December 2020

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer

1 reference

12 December 2020

Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study

1 reference

12 December 2020

The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated

1 reference

12 December 2020

Cardiotoxicity after childhood cancer: beginning with the end in mind

1 reference

12 December 2020

Increased risk of cardiac dysfunction after anthracyclines in girls

1 reference

12 December 2020

Severe and fatal anthracycline cardiotoxicity at cumulative doses below 400 mg/m2: evidence for enhanced toxicity with multiagent chemotherapy

1 reference

12 December 2020

Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease

1 reference

12 December 2020

Characterization of the cycle of iron-mediated electron transfer from Adriamycin to molecular oxygen

1 reference

12 December 2020

Late cardiotoxicity after treatment for Hodgkin lymphoma

1 reference

12 December 2020

1 reference

12 December 2020

Noninvasive Evaluation of Late Anthracycline Cardiac Toxicity in Childhood Cancer Survivors

1 reference

12 December 2020

Ventricular late potentials: another expression of cardiotoxicity of cytostatic drugs in children?

1 reference

12 December 2020

Increased pretransplant QT dispersion as a risk factor for the development of cardiac complications during and after preparative conditioning for pediatric allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Impaired vascular function in asymptomatic young adult survivors of Hodgkin Lymphoma following mediastinal radiation

1 reference

12 December 2020

Cardiotoxicity Associated With High-Dose Cyclophosphamide Therapy

1 reference

12 December 2020

High risk of symptomatic cardiac events in childhood cancer survivors

1 reference

12 December 2020

Epidemiology of anthracycline cardiotoxicity in children and adults.

1 reference

12 December 2020

Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Delayed cardiac toxicity from anthracycline therapy

1 reference

12 December 2020

Cardiac disease following treatment of Hodgkin's disease in children and adolescents

1 reference

12 December 2020

Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor

1 reference

12 December 2020

Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings

1 reference

12 December 2020

N-terminal pro brain natriuretic peptide and cardiac function in doxorubicin administered pediatric patients.

1 reference

12 December 2020

Presence of prolonged dispersion of qt intervals in late survivors of childhood anthracycline therapy

1 reference

12 December 2020

Cardiac function in survivors of acute lymphoblastic leukaemia and Hodgkin's lymphoma

1 reference

12 December 2020

Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy.

1 reference

12 December 2020

Longitudinal evaluation of anthracycline cardiotoxicity by signal-averaged electrocardiography in children with cancer

1 reference

12 December 2020

Anthracyclines for acute lymphoblastic leukemia in a child with congenital long QT syndrome

1 reference

12 December 2020

Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study

1 reference

12 December 2020

Mechanism of 'inappropriate' sinus tachycardia. Role of sympathovagal balance.

1 reference

12 December 2020

10.1007/S00431-013-1931-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

23 February 2020

1017704693

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23361962%20AND%20SRC:MED&resulttype=core&format=json